absorption
two
antibacterial
drugs
cephalexin
co
trimoxazole
malabsorption
syndromes
plasma
concentrations
urinary
excretion
cephalexin
trimethoprim
sulphamethoxazole
co
trimoxazole
measured
normal
subjects
patients
coeliac
disease
small
bowel
diverticulosis
crohn
disease
cystic
fibrosis
cephalexin
administration
cholestyramine
absorption
cephalexin
improved
coeliac
disease
diverticulosis
cystic
fibrosis
crohn
disease
peak
plasma
level
reduced
delayed
absorption
trimethoprim
sulphamethoxazole
increased
three
conditions
however
disproportionate
increase
plasma
level
trimethoprim
coeliac
disease
diverticulosis
compared
sulphamethoxazole
crohn
disease
threefold
increase
peak
plasma
level
sulphamethoxazole
cholestyramine
administration
malabsorption
three
drugs
